Barclays

Barclays’s Entrada Therapeutics TRDA Stock Holding History

Barclays’s Portfolio TRDA Stock Details TRDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$362K	Sell	28,676 -38,471	-57%	-$441K	﹤0.01%	3369
2025 Q4	$690K	Buy	67,147 +6,517	+11%	+$54.9K	﹤0.01%	3673
2025 Q3	$352K	Buy	60,630 +2,548	+4%	+$14.9K	﹤0.01%	4001
2025 Q2	$390K	Buy	58,082 +18,431	+46%	+$148K	﹤0.01%	3897
2025 Q1	$358K	Sell	39,651 -11,714	-23%	-$146K	﹤0.01%	3726
2024 Q4	$888K	Buy	51,365 +6,255	+14%	+$113K	﹤0.01%	3453
2024 Q3	$721K	Buy	45,110 +30,585	+211%	+$482K	﹤0.01%	3561
2024 Q2	$207K	Sell	14,525 -7,992	-35%	-$114K	﹤0.01%	3557
2024 Q1	$319K	Sell	22,517 -9,213	-29%	-$130K	﹤0.01%	3854
2023 Q4	$479K	Buy	31,730 +25,798	+435%	+$382K	﹤0.01%	3903
2023 Q3	$93.7K	Sell	5,932 -508	-8%	-$8K	﹤0.01%	3621
2023 Q2	$97.5K	Sell	6,440 -3,788	-37%	-$52.2K	﹤0.01%	3575
2023 Q1	$148K	Sell	10,228 -544	-5%	-$7.26K	﹤0.01%	3967
2022 Q4	$146K	Buy	10,772 +9,557	+787%	+$168K	﹤0.01%	4012
2022 Q3	$19K	Buy	1,215 +1,179	+3,275%	+$15K	﹤0.01%	4083
2022 Q2	$0	Sell	36 -1,673	-98%	-$12.7K	﹤0.01%	5271
2022 Q1	$16K	Buy	+1,709	New	+$18.3K	﹤0.01%	4509

Other funds holding TRDA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return